Cargando…
A Rationally Engineered Capsid Variant of AAV9 for Systemic CNS-Directed and Peripheral Tissue-Detargeted Gene Delivery in Neonates
Adeno-associated virus (AAV) has provided the gene therapy field with the most powerful in vivo gene delivery vector to realize safe, efficacious, and sustainable therapeutic gene expression. Because many clinically relevant properties of AAV-based vectors are governed by the capsid, much research e...
Autores principales: | Wang, Dan, Li, Shaoyong, Gessler, Dominic J., Xie, Jun, Zhong, Li, Li, Jia, Tran, Karen, Van Vliet, Kim, Ren, Lingzhi, Su, Qin, He, Ran, Goetzmann, Jason E., Flotte, Terence R., Agbandje-McKenna, Mavis, Gao, Guangping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5948233/ https://www.ncbi.nlm.nih.gov/pubmed/29766031 http://dx.doi.org/10.1016/j.omtm.2018.03.004 |
Ejemplares similares
-
Rationally Engineered AAV Capsids Improve Transduction and Volumetric Spread in the CNS
por: Kanaan, Nicholas M., et al.
Publicado: (2017) -
Mapping the AAV Capsid Host Antibody Response toward the Development of Second Generation Gene Delivery Vectors
por: Tseng, Yu-Shan, et al.
Publicado: (2014) -
Adeno-associated Virus (AAV) Capsid Chimeras with Enhanced Infectivity Reveal a Core Element in the AAV Genome Critical for both Cell Transduction and Capsid Assembly
por: Viney, Lydia, et al.
Publicado: (2021) -
Completion of the AAV Structural Atlas: Serotype Capsid Structures Reveals Clade-Specific Features
por: Mietzsch, Mario, et al.
Publicado: (2021) -
Naturally occurring singleton residues in AAV capsid impact vector performance and illustrate structural constraints
por: Vandenberghe, Luk H., et al.
Publicado: (2009)